These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 15730222)
41. A cost-effectiveness evaluation of single and combined smoking cessation interventions in Texas. Hill A Tex Med; 2006 Aug; 102(8):50-5. PubMed ID: 17115560 [No Abstract] [Full Text] [Related]
42. Treating nicotine dependence. Glover ED; Glover PN W V Med J; 2001; 97(1):39-43. PubMed ID: 11257836 [TBL] [Abstract][Full Text] [Related]
43. Are there any new strategies to increase the success rate for smoking cessation? Wewers ME; Burkley AR Perspect Respir Nurs; 1998 Feb; 9(1):5, 10. PubMed ID: 10808911 [No Abstract] [Full Text] [Related]
44. [Drugs for smoking cessation]. Tonstad S Tidsskr Nor Laegeforen; 2005 Jan; 125(2):178-80. PubMed ID: 15665893 [No Abstract] [Full Text] [Related]
45. The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation. Escobar-Chávez JJ; Merino V; López-Cervantes M; Rodríguez-Cruz IM; Quintanar-Guerrero D; Ganem-Quintanar A Curr Drug Discov Technol; 2009 Sep; 6(3):171-85. PubMed ID: 19496753 [TBL] [Abstract][Full Text] [Related]
46. How does bupropion work as a smoking cessation aid? Warner C; Shoaib M Addict Biol; 2005 Sep; 10(3):219-31. PubMed ID: 16109583 [TBL] [Abstract][Full Text] [Related]
49. Bupropion for the treatment of nicotine withdrawal and craving. Mooney ME; Sofuoglu M Expert Rev Neurother; 2006 Jul; 6(7):965-81. PubMed ID: 16831112 [TBL] [Abstract][Full Text] [Related]
50. Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal. Wing VC; Shoaib M Psychopharmacology (Berl); 2007 Dec; 195(3):303-13. PubMed ID: 17690868 [TBL] [Abstract][Full Text] [Related]
51. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. Becker KM; Rose JE; Albino AP Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723 [TBL] [Abstract][Full Text] [Related]
52. PHARMAC and tobacco control in New Zealand: two licensed funded options are already available. Metcalfe S; Moodie P; McNee W N Z Med J; 2005 Jun; 118(1217):U1544; author reply U1544; discussion U1544. PubMed ID: 15980915 [No Abstract] [Full Text] [Related]
53. No gender difference in effectiveness of smoking cessation treatment in a Brazilian real-life setting. Chatkin JM; Abreu CM; Blanco DC; Tonietto R; Scaglia N; Wagner MB; Fritscher CC Int J Tuberc Lung Dis; 2006 May; 10(5):499-503. PubMed ID: 16704030 [TBL] [Abstract][Full Text] [Related]
54. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases. Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511 [TBL] [Abstract][Full Text] [Related]